Evidence map›Paper›PMID 35815410›Full record

ArticleThe EMBO journal2022

Schwann cell precursors represent a neural crest-like state with biased multipotency.

Maria Eleni Kastriti, Louis Faure, Dorothea Von Ahsen, Thibault Gerald Bouderlique, Johan Boström, Tatiana Solovieva, Cameron Jackson, Marianne Bronner, Dies Meijer, Saida Hadjab and 10 more

Open access · hybridAbstract read
In one paragraph

Article in The EMBO journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 77 papers.

0numbers the graph read from it
0cells of the map it votes in
77citing papers in PubMed
9.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

77 citing papers in PubMed, 109 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Epigenetic crosstalk in neuroblastoma development and progression.Frontiers in cell and developmental biology · 2026
    Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

17 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 8 institutions in 8 countries.

Maria Eleni Kastriti *Department of Molecular Neuroscience, Center for Brain Research, Medical University Vienna, Vienna, Austria.ORCID 0000-0002-0563-7399
Louis Faure *Department of Neuroimmunology, Center for Brain Research, Medical University Vienna, Vienna, Austria.ORCID 0000-0003-4621-586X
Dorothea Von Ahsen *Department of Neuroimmunology, Center for Brain Research, Medical University Vienna, Vienna, Austria.
Thibault Gerald BouderliqueDepartment of Neuroimmunology, Center for Brain Research, Medical University Vienna, Vienna, Austria.
Johan BoströmDepartment of Neuroimmunology, Center for Brain Research, Medical University Vienna, Vienna, Austria.ORCID 0000-0001-5252-4023
Tatiana SolovievaDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA.ORCID 0000-0001-6194-2550
Cameron JacksonDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA.
Marianne BronnerDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA.ORCID 0000-0003-4274-1862
Dies MeijerCentre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, UK.ORCID 0000-0002-8461-6341
Saida HadjabDepartment of Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Francois LallemendDepartment of Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Alek EricksonDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
Marketa KauckaMax Planck Institute for Evolutionary Biology, Plön, Germany.ORCID 0000-0002-8781-9769
Viacheslav DyachukAlmazov Federal Medical Research Centre, Saint Petersburg, Russia.
Thomas PerlmannDepartment of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden.
Laura LahtiDepartment of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden.
Jan KrivanekDepartment of Histology and Embryology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.ORCID 0000-0002-7590-187X
Jean-Francois BrunetInstitut de Biologie de l'ENS (IBENS), INSERM, CNRS, École Normale Supérieure, PSL Research University, Paris, France.
Kaj FriedDepartment of Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Igor AdameykoDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0001-5471-0356
Karolinska Institutet · SEMedical University of Vienna · ATCalifornia Institute of Technology · USCentre National de la Recherche Scientifique · FRFederal Almazov North-West Medical Research Centre · RUMasaryk University · CZMax Planck Institute for Evolutionary Biology · DEUniversity of Edinburgh · GB

Funding

Clonal analysis of the cranial neural crestR01DE027568 · NIDCR · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI BRONNER, MARIANNE · 2018 to 2022
$2.2M
Signaling mechanisms underlying neural crest cell fate decisionsF32DE029662 · NIDCR · KAROLINSKA INSTITUTE · PI ERICKSON, ALEK G · 2021 to 2023
$219k
Austrian Science Fund FWF DOC 33Austrian Science Fund FWF M 2688NIDCR NIH HHS F32 DE029662NIDCR NIH HHS R01 DE027568
6 · The paper itself

Abstract

Schwann cell precursors (SCPs) are nerve-associated progenitors that can generate myelinating and non-myelinating Schwann cells but also are multipotent like the neural crest cells from which they originate. SCPs are omnipresent along outgrowing peripheral nerves throughout the body of vertebrate embryos. By using single-cell transcriptomics to generate a gene expression atlas of the entire neural crest lineage, we show that early SCPs and late migratory crest cells have similar transcriptional profiles characterised by a multipotent "hub" state containing cells biased towards traditional neural crest fates. SCPs keep diverging from the neural crest after being primed towards terminal Schwann cells and other fates, with different subtypes residing in distinct anatomical locations. Functional experiments using CRISPR-Cas9 loss-of-function further show that knockout of the common "hub" gene Sox8 causes defects in neural crest-derived cells along peripheral nerves by facilitating differentiation of SCPs towards sympathoadrenal fates. Finally, specific tumour populations found in melanoma, neurofibroma and neuroblastoma map to different stages of SCP/Schwann cell development. Overall, SCPs resemble migrating neural crest cells that maintain multipotency and become transcriptionally primed towards distinct lineages.

Indexed as

Neural CrestSchwann CellsCell DifferentiationNeurogenesisPeripheral Nervesmultipotencyneural crestregulonsSchwann cell lineageSchwann cell precursors

Identifiers

PMID35815410
PMCPMC9434083
OpenAlexW4285009752

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.